Fallot’s Disease (Tetrad, Triad, Pentad) in the Structure of Congenital Heart Defects in the Azerbaijani Population
DOI:
https://doi.org/10.6000/1929-4247.2026.15.01.3Keywords:
Newborns, preeclampsia, cardiology, children, prenatal screening, pregnancyAbstract
Background: The aim of the study was to identify the main factors influencing the development of these heart defects, as well as to assess the demographic and medical characteristics of patients.
Method: A retrospective, multicenter study was conducted across nine regions of Azerbaijan, including Baku and Sumgait, analyzing medical records from maternity hospitals and cardiology centres between 2020 and 2023. Of 2,000 confirmed CHD cases, 994 newborns had complete medical documentation and were included in the analysis. According to regional perinatal statistics, these cases corresponded to an estimated ~165,000 live births, providing population-level denominators. Clinical, demographic, maternal, and perinatal variables were analyzed using descriptive statistics, chi-square tests, and multivariable logistic regression, with odds ratios (OR) and 95% confidence intervals (CI).
Results: Of the 994 CHD cases, 7.24% (n=72) had Fallot disease, including 3.82% (n=38) with Fallot triad, 2.11% (n=21) with Fallot tetrad, and 1.31% (n=13) with Fallot pentad. The incidence of CHD varied significantly by region, potentially due to differences in healthcare, genetic predisposition, and socio-economic factors. Risk factors for Fallot disease included maternal chronic diseases (35.1%), complications during pregnancy (such as pre-eclampsia, 25.5%), and obstetric interventions (18.4%). A gender imbalance was observed, with 57.3% of patients being male. The study highlighted the importance of early diagnosis, despite 70.3% of mothers undergoing antenatal check-ups, with no prenatal diagnosis of Fallot disease.
Conclusions: The analysis of demographic indicators showed an imbalance in the sex ratio of patients, which may indicate varying degrees of vulnerability to the development of serious conditions. The study also demonstrated the need to improve screening programmes and expand diagnostic capabilities to detect these cardiac anomalies early. The results provide a basis for further research aimed at developing more effective methods to prevent and treat this condition, as well as to assess the long-term health consequences for patients.
References
Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153(6): 807-13. DOI: https://doi.org/10.1016/j.jpeds.2008.05.059
Liu Y, Chen S, Zühlke L, Black GC, Choy M-K, Li N, et al. Global birth prevalence of congenital heart defects 1970-2017: Updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 2019; 48(2): 455-63. DOI: https://doi.org/10.1093/ije/dyz009
Anduaga I, Affronti A, Cepas-Guillén P, Alcocer J, Flores-Umanzor E, Regueiro A, et al. Non-pharmacological stroke prevention in atrial fibrillation. J Clin Med 2023; 12(17): 5524. DOI: https://doi.org/10.3390/jcm12175524
Tramontin C, Affronti A, Cirio EM. Diagnostic and surgical management of HeartMate 3 outflow graft obstruction due to two different mechanisms. Asian Cardiovasc Thorac Ann 2022; 30(7): 826-9. DOI: https://doi.org/10.1177/02184923221106765
Bailliard F, Anderson RH. Tetralogy of Fallot. Orphanet J Rare Dis 2009; 4: 2. DOI: https://doi.org/10.1186/1750-1172-4-2
Merkhatuly N, Iskanderov A, Abeuova S, Iskanderov A, Zhokizhanova S. Introduction of electron donor groups into the azulene structure: The appearance of intense absorption and emission in the visible region. Mol 2024; 29(14): 3354. DOI: https://doi.org/10.3390/molecules29143354
Van Praagh R. Diagnosis of complex congenital heart disease: Morphologic-anatomic method and terminology. Cardiovasc Intervent Radiol 1984; 7: 115-20. DOI: https://doi.org/10.1007/BF02552810
Althali NJ, Hentges KE. Genetic insights into non-syndromic Tetralogy of Fallot. Front Physiol 2022; 13: 1012665. DOI: https://doi.org/10.3389/fphys.2022.1012665
Egbe AC, Crestanello J, Dearani JA, Karim O, Banala K, Angirekula M, et al. Long-term outcomes in adults with repaired tetralogy of Fallot and pulmonary atresia. Cardiol Young 2019; 29(8): 1078-81. DOI: https://doi.org/10.1017/S1047951119001598
Mamasoula C, Addor MC, Carbonell CC, Dias CM, Echevarría-González-De-Garibay LJ, Gatt M, et al. Prevalence of congenital heart defects in Europe, 2008-2015: A registry-based study. Birth Defects Res 2022; 114(20): 1404-16. DOI: https://doi.org/10.1002/bdr2.2117
Geva T, Wald RM, Bucholz E, Cnota JF, McElhinney DB, Mercer-Rosa LM, et al. Long-term management of right ventricular outflow tract dysfunction in repaired Tetralogy of Fallot: A scientific statement from the American Heart Association. Circ 2024; 150(25): e689-707. DOI: https://doi.org/10.1161/CIR.0000000000001291
Miller JR, Stephens EH, Goldstone AB, Goldstone AB, Glatz AC, Kane L, et al. The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with Tetralogy of Fallot. J Thorac Cardiovasc Surg 2023; 165(1): 221-50. DOI: https://doi.org/10.1016/j.jtcvs.2022.07.025
Dong W, Kaymakcalan H, Jin SC, Diab NS, Tanıdır C, Yalcin ASY, et al. Mutation spectrum of congenital heart disease in a consanguineous Turkish population. Mol Genet Genomic Med 2022; 10(6): e1944. DOI: https://doi.org/10.1002/mgg3.1944
Albesher N, Massadeh S, Hassan SM, Alaamery M. Consanguinity and congenital heart disease susceptibility: Insights into rare genetic variations in Saudi Arabia. Genes 2022; 13(2): 354. DOI: https://doi.org/10.3390/genes13020354
Vanderlaan RD, Barron DJ. Optimal surgical management of Tetralogy of Fallot. CJC Pediatr Congenit Heart Dis 2023; 2(6): 352-60. DOI: https://doi.org/10.1016/j.cjcpc.2023.09.003
Flores-Umanzor E, Alshehri B, Keshvara R, Wilson W, Osten M, Benson L, et al. Transcatheter-based interventions for Tetralogy of Fallot across all age groups. JACC Cardiovasc Interv 2024; 17(9): 1079-90. DOI: https://doi.org/10.1016/j.jcin.2024.02.009
Ibragimov B, Khudoyarova D, Ibragimova N, Kobilova Z. Fertility recovery from polycystic ovarian syndrome. Int J Pharm Res 2020; 12(4): 592-6. DOI: https://doi.org/10.31838/ijpr/2020.12.04.096
Lisiecka MZ. Subcutaneous immunotherapy against tree pollen, grass pollen, artemisia pollen, Alternaria alternata and house dust mites efficiency mediators: A review. Int J Bio Chem Sci 2024; 18(2): 647-54.
Kasian S, Loboda A, Smiyan O, Popov S, Petrashenko V, Zahorodnii M, et al. The lead content in biological media of term infants with hypoxic-ischemic CNS. Bangladesh J Med Sci 2021; 20(2): 330-3. DOI: https://doi.org/10.3329/bjms.v20i2.51543
Lisiecka MZ. Subcutaneous immunotherapy against tree pollen, grass pollen, artemisia pollen, Alternaria alternata and house dust mites efficiency mediators: A review. Int J Bio Chem Sci 2024; 18(2): 647-54. DOI: https://doi.org/10.4314/ijbcs.v18i2.25
Shuliha-Nedaikhliebova OV, Kovalova AV, Kuzyk PV, Salamakha OO, Zokhniuk NM, Shul OM, et al. Idiopathic granulomatous mastitis: A clinical case and a review of the literature. Zaporozhye Med J 2022; 24(2): 254-62. DOI: https://doi.org/10.14739/2310-1210.2022.2.233123
Popov SV, Profatylo AO, Turner MA, Smiian O, Vasylieva OG. Features of the progression of the inflammatory response in newborns with neonatal encephalopathy. East Ukr Med J 2024; 12(1): 50-60. DOI: https://doi.org/10.21272/eumj.2024;12(1):50-60
Tutchenko M, Rudyk D, Besedinskyi M, Chub S. Spontaneous bacterial peritonitis. East Ukr Med J 2024; 12(2): 221-8. DOI: https://doi.org/10.21272/eumj.2024;12(2):221-228
Meloni P, Izzo S, De Intinis C, Simari T, Motzo M, Picazzo R, et al. Rare complication post-conization for cervical dysplasia: Rectovaginal fistula. Clin Pract 2023; 13(5): 1025-34. DOI: https://doi.org/10.3390/clinpract13050091
Susak YaM, Palitsa RYa, Markulan LYu, Maksуmenko MV. Infection of the biliary tract during palliative drainage in patients with hilar malignant jaundice. Emerg Med Ukr 2021; 17(2): 79-86. DOI: https://doi.org/10.22141/2224-0586.17.2.2021.230653
Lukyanenko N, Lenha E, Spaska A, Klets T, Shevchenko T. Tactics for treating young children with pyelonephritis and vesicoureteral reflux associated with impaired fibrillogenesis. Mol Cell Biochem 2023; 478(3): 531-8. DOI: https://doi.org/10.1007/s11010-022-04529-7
Merkhatuly N, Iskanderov AN, Zhokizhanova SK, Kezdikbaeva, AT, Ibraeva, AK. Stereoselective synthesis of cis-eudesmane esters based on (−)-α-santonin. Chem Nat Compd 2017; 53(3): 582-3. DOI: https://doi.org/10.1007/s10600-017-2057-5
Ilderbayeva G, Utegenova A, Ilderbayev O, Sembaeva Z, Askarova G. Assessment of the combined effects of heavy metal cobalt and sublethal radiation on the immune system. Biomed Biotech Res J 2024; 8(4): 455-63. DOI: https://doi.org/10.4103/bbrj.bbrj_316_24
van der Linde D, Konings EEM, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol 2011; 58(21): 2241-7. DOI: https://doi.org/10.1016/j.jacc.2011.08.025
Dolk H, Loane M, Garne E, EUROCAT Working Group. Congenital heart defects in Europe: Prevalence and perinatal mortality, 2000 to 2005. Circ 2011; 123(8): 841-9. DOI: https://doi.org/10.1161/CIRCULATIONAHA.110.958405
Huang C, Li J, Qin G, Liew Z, Hu J, László KD, et al. Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease: A national population-based cohort study. PLoS Med 2021; 18(9): e1003805. DOI: https://doi.org/10.1371/journal.pmed.1003805
Lastivka IV, Pishak VP, Ryznychuk MO, Khmara TV. Risk factor analysis for congenital heart defects in children. Regul Mech Biosyst 2020; 11(4): 524-30. DOI: https://doi.org/10.15421/022080
Using foetal heart ultrasound to diagnose congenital heart disease 2024. Available from: https://rh.ua/statti/vikoristannya-ultrazvuku-sercya-ploda-dlya-diagnostiki-vrodzhenix-vad-sercya/
Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39(12): 1890-900. DOI: https://doi.org/10.1016/S0735-1097(02)01886-7
Hu H, Chen W, Sheng W, Huang G. High familial recurrence of congenital heart defects in laterality defects patients: An evaluation of 184 families. Pediatr Cardiol 2021; 42(8): 1722-9. DOI: https://doi.org/10.1007/s00246-021-02656-4
Hedermann G, Hedley PL, Gadsbøll K, Thagaard IN, Krebs L, Karlsen MA, et al. Adverse obstetric outcomes in pregnancies with major foetal congenital heart defects: A cohort study. Ultrasound Obstet Gynecol 2024; 64(S1): 24. DOI: https://doi.org/10.1002/uog.27782
Dorn C, Perrot A, Grunert M, Rickert-Sperling S. Human genetics of tetralogy of Fallot and double-outlet right ventricle. In: Rickert-Sperling S, Kelly RG, Haas N, editors. Congenital Heart Diseases: The Broken Heart: Clinical Features, Human Genetics and Molecular Pathways. Cham: Springer; 2024; pp. 629-44. DOI: https://doi.org/10.1007/978-3-031-44087-8_36
Wojczakowski W, Kimber-Trojnar Ż, Dziwisz F, Słodzińska M, Słodziński H, Leszczyńska-Gorzelak B. Preeclampsia and cardiovascular risk for offspring. J Clin Med 2021; 10(14): 3154. DOI: https://doi.org/10.3390/jcm10143154
Turunen R, Pulakka A, Metsälä J, Vahlberg T, Ojala T, Gissler M, et al. Maternal diabetes and overweight and congenital heart defects in offspring. JAMA Netw Open 2024; 7(1): e2350579. DOI: https://doi.org/10.1001/jamanetworkopen.2023.50579
Cheng Z, Gu R, Lian Z, Gu HF. Evaluation of the association between maternal folic acid supplementation and the risk of congenital heart disease: A systematic review and meta-analysis. Nutr J 2022; 21(1): 20. DOI: https://doi.org/10.1186/s12937-022-00772-2
Wondemagegn AT, Afework M. The association between folic acid supplementation and congenital heart defects: systematic review and meta-analysis. SAGE Open Med 2022; 10: 20503121221081069. DOI: https://doi.org/10.1177/20503121221081069
Dhanya MS, Karthick S, Alex RB, Anandhi D, Athira BP, Lash KK, et al. The influence of maternal infections on congenital heart defect. J Adv Zool 2024; 45(1): 719-38.
Wu X, Peng S. Maternal hepatitis B virus infection and risk of congenital heart diseases. JAMA Pediatr 2023; 177(9): 980-1. DOI: https://doi.org/10.1001/jamapediatrics.2023.2009
Obeagu EI, Obeagu GU. Hypoxia in pregnancy: implications for foetal development. Int J Curr Res Chem Pharm Sci 2024; 11(8): 1-12. DOI: https://doi.org/10.22270/ijmspr.v11i1.137
Waern M, Mellander M, Berg A, Carlsson Y. Prenatal detection of congenital heart disease: results of a Swedish screening program 2013-2017. BMC Pregnancy Childbirth 2021; 21: 579. DOI: https://doi.org/10.1186/s12884-021-04028-5
Published
How to Cite
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
